Cromoglicic acid
- Generic Name
- Cromoglicic acid
- Brand Names
- Gastrocrom, Nalcrom, Nasalcrom
- Drug Type
- Small Molecule
- Chemical Formula
- C23H16O11
- CAS Number
- 16110-51-3
- Unique Ingredient Identifier
- Y0TK0FS77W
- Background
A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
- Indication
For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
- Associated Conditions
- Asthma, Conjunctivitis, Vernal, Exercise-Induced Bronchospasm, Food Allergy, Keratoconjunctivitis, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Conjunctivitis, Seasonal Allergic Rhinitis, Urticaria Pigmentosa, Vernal Keratoconjunctivitis
- Associated Therapies
- -
Cromoglicate in Mastocytosis
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2013-03-07
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 7
- Registration Number
- NCT01701843
- Locations
- 🇩🇪
Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
Treatment of Acute Stroke With Cromolyn(Single Dose)
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2010-08-05
- Lead Sponsor
- Wolfson Medical Center
- Registration Number
- NCT01175525
- Locations
- 🇮🇱
Edith wolfson medical Center, Holon, Israel
Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
- Conditions
- Interventions
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2009-08-18
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 62
- Registration Number
- NCT00745199
- Locations
- 🇮🇷
Shiraz University of Medical sciences, Nemazi and Faghihi Hospital, Shiraz, Fars, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.